Question 1

What is the catalog number for NATtrol Influenza A/B Positive Control?

Accepted Answer

The catalog number for NATtrol Influenza A/B Positive Control is NATFLUAB-6C.

Question 2

What sizes are available for NATtrol Influenza A/B Positive Control?

Accepted Answer

NATtrol Influenza A/B Positive Control is available in the following size(s): 6x 0.5 mL.

Question 3

Is NATtrol Influenza A/B Positive Control in stock?

Accepted Answer

NATtrol Influenza A/B Positive Control is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Who manufactures NATtrol Influenza A/B Positive Control?

Accepted Answer

NATtrol Influenza A/B Positive Control is manufactured by ZPTX.

Question 5

What is the estimated delivery time for NATtrol Influenza A/B Positive Control?

Accepted Answer

Estimated delivery time for NATtrol Influenza A/B Positive Control is approximately 10 business day(s), depending on your location.

Question 6

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 7

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 8

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

NATtrol Influenza A/B Positive Control

Product Specifications

Type

Field of Research

Frequently Asked Questions

Explore Other Products

Prdm1 Rat shRNA Plasmid (Locus ID 309871)

TOM1 Antibody, HRP conjugated

RAMP3 Polyclonal Antibody, AbBy Fluor™ 594 Conjugated

Ifih1 (NM_001164477) Mouse Recombinant Protein

MKL2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)

RND1 293 Cell Lysate